2016
DOI: 10.1183/13993003.00399-2016
|View full text |Cite
|
Sign up to set email alerts
|

Are COPD and cardiovascular disease fundamentally intertwined?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
4
0

Year Published

2017
2017
2019
2019

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 32 publications
0
4
0
Order By: Relevance
“…However, the relationship between platelet count measured in the stable phase of COPD and all-cause mortality has not been previously explored. Furthermore, comorbid COPD and CV disease has been associated with higher rates of morbidity than presence of either disease alone making this a particularly vulnerable population [21]. Using data from the Study to Understand Mortality and Morbidity in COPD (SUMMIT), a prospective randomized controlled trial enriched for presence of CV comorbidity and containing adjudicated events, we investigated post hoc the association of platelet count measured in the stable phase of COPD with all-cause mortality, CV and respiratory outcomes.…”
Section: Introductionmentioning
confidence: 99%
“…However, the relationship between platelet count measured in the stable phase of COPD and all-cause mortality has not been previously explored. Furthermore, comorbid COPD and CV disease has been associated with higher rates of morbidity than presence of either disease alone making this a particularly vulnerable population [21]. Using data from the Study to Understand Mortality and Morbidity in COPD (SUMMIT), a prospective randomized controlled trial enriched for presence of CV comorbidity and containing adjudicated events, we investigated post hoc the association of platelet count measured in the stable phase of COPD with all-cause mortality, CV and respiratory outcomes.…”
Section: Introductionmentioning
confidence: 99%
“… 28 Moreover, the potential cardiopulmonary interactions may also contribute to the result. 7 In the current study, the plasma concentrations of NT-proBNP in the elderly patients with AECOPD associated with LHF were markedly elevated, as compared with those with AECOPD only. ROC curves for the plasma concentrations of NT-proBNP were obtained as a diagnostic test for LHF in the elderly patients with AECOPD.…”
Section: Discussionmentioning
confidence: 44%
“…Unfortunately, due to an overlap in clinical presentation between AECOPD and LHF, including exertional dyspnea, easy fatigability, nocturnal cough, wheezing, etc., the timely identification of AECOPD associated with LHF is currently challenging and needs a high degree of clinical suspicion. 5 7 In the current study, the majority of the enrolled patients experienced dyspnea or decreased exercise tolerance, and abnormal pulmonary sounds were common. However, clinical examinations with sufficient accuracy to diagnose AECOPD coexisting with LHF are not always available in routine practice.…”
Section: Discussionmentioning
confidence: 71%
See 1 more Smart Citation